Role of aneuploid circulating tumor cells and CD31 + circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC-Reference-Cited by-同舟云学术

Role of aneuploid circulating tumor cells and CD31 + circulating tumor endothelial cells in predicting and monitoring anti‐angiogenic therapy efficacy in advanced NSCLC

Published:2021-09-12 Issue:11 Volume:15 Page:2891-2909
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Zhang Tongmei¹^ORCID,Zhang Lina²^ORCID,Gao Yuan¹,Wang Ying¹,Liu Yanxia¹,Zhang Hongmei¹,Wang Qunhui¹,Hu Fanbin¹,Li Jie¹,Tan Jinjing²,Wang Daisy Dandan³,Gires Olivier⁴^ORCID,Lin Peter Ping³^ORCID,Li Baolan¹

Affiliation:

1. Department of Medical Oncology, Beijing Chest Hospital Capital Medical University Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing China

2. Department of Cellular and Molecular Biology Beijing Chest Hospital, Capital Medical University Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing China

3. Cytelligen San Diego CA USA

4. Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital LMU Munich Germany

Funder

Deutsche Forschungsgemeinschaft

Beijing Municipal Science and Technology Commission

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13092

Reference61 articles.